PlainRecalls
FDA Drug Moderate Class II Terminated

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC., Lenoir, NC 28645, NDC 51754-5001-1

Reported: January 19, 2022 Initiated: January 11, 2022 #D-0369-2022

Product Description

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC., Lenoir, NC 28645, NDC 51754-5001-1

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
Exela Pharma Sciences LLC
Units Affected
18,960 vials
Distribution
Nationwide within the United States
Location
Lenoir, NC

Frequently Asked Questions

What product was recalled?
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC., Lenoir, NC 28645, NDC 51754-5001-1. Recalled by Exela Pharma Sciences LLC. Units affected: 18,960 vials.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on January 19, 2022. Severity: Moderate. Recall number: D-0369-2022.